A Double-Blind Randomized Controlled Trial of N -Acetylcysteine in Cannabis-Dependent Adolescents

Gray, Kevin M., Carpenter, Matthew J., Baker, Nathaniel L., DeSantis, Stacia M., Kryway, Elisabeth, Hartwell, Karen J., McRae-Clark, Aimee L., Brady, Kathleen T.·2012·American Journal of Psychiatry

Cited by (306)

Items 101–200 of 306

  1. Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder
    Rachel L. Tomko, Nathaniel L. Baker, Caitlyn O. Hood, Amanda K. Gilmore, Erin A. McClure, Lindsay M. Squeglia, Aimee L. McRae‐Clark, Susan C. Sonne, Kevin Michael Gray · 2019 · Psychopharmacology
  2. Protecting children and adolescents against the risks of vaping
    Nicholas Chadi, Ellie Vyver, Richard E. Bélanger · 2021 · Paediatrics & Child Health
  3. Integrated Treatment of Adolescents with Co-occurring Depression and Substance Use Disorder
    Hinckley, Jesse D., Riggs, Paula · 2019 · Child and Adolescent Psychiatric Clinics of North America
  4. Cognitive performance in a placebo-controlled pharmacotherapy trial for youth with marijuana dependence
    Amanda T. Roten, Nathaniel L. Baker, Kevin Michael Gray · 2015 · Addictive Behaviors
  5. Treatment with Adjunctive <i>N</i> -Acetylcysteine in an Adolescent with Selective Serotonin Reuptake Inhibitor-Resistant Anxiety
    Strawn, Jeffrey R., Saldaña, Shannon N. · 2012 · Journal of Child and Adolescent Psychopharmacology
  6. Low Pretreatment Impulsivity and High Medication Adherence Increase the Odds of Abstinence in a Trial of N-Acetylcysteine in Adolescents with Cannabis Use Disorder
    Jessica P. Bentzley, Rachel L. Tomko, Kevin Michael Gray · 2015 · Journal of Substance Abuse Treatment
  7. Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol
    Agonist Replacement for Cannabis Dependence (ARCD) study group, Anjali K. Bhardwaj, David J. Allsop, Jan Copeland, Iain S. McGregor, Adrian John Dunlop, Marian Shanahan, Raimondo Bruno, Nghi Phung, Mark Enea Montebello et al. · 2018 · BMC Psychiatry
  8. The neuroprotective effects of N-acetylcysteine in psychiatric and neurodegenerative disorders: From modulation of glutamatergic transmission to restoration of synaptic plasticity
    Suwarna Chakraborty, Shankaranarayana Rao, Sunil Jamuna Tripathi · 2025 · Neuropharmacology
  9. A scoping review and meta-analysis of psychosocial and pharmacological treatments for cannabis and tobacco use among African Americans.
    LaTrice Montgomery, Cendrine D. Robinson, Elizabeth L. Seaman, Angela M. Haeny · 2017 · Psychology of Addictive Behaviors
  10. Reprint of The effect of N-acetylcysteine and working memory training on cocaine use, craving and inhibition in regular cocaine users: correspondence of lab assessments and Ecological Momentary Assessment
    Mieke H. J. Schulte, Reinout W. H. J. Wiers, Wouter J. Boendermaker, Anna E. Goudriaan, Wim van den Brink, Denise S. van Deursen, Malte Friese, Emily Brede, Andrew J. Waters · 2018 · Addictive Behaviors
  11. Non-abstinent treatment outcomes for cannabis use disorder
    FRANCES RUDNICK LEVIN, John J. Mariani, C. Jean Choi, Cale Neil Basaraba, Daniel J. Brooks, Christina Brezing, Martina Pavlicová · 2021 · Drug and Alcohol Dependence
  12. Stress- and drug-induced neuroimmune signaling as a therapeutic target for comorbid anxiety and substance use disorders
    Cora E. Smiley, Susan K. Wood · 2022 · Pharmacology & Therapeutics
  13. Narrative Review: Revised Principles and Practice Recommendations for Adolescent Substance Use Treatment and Policy
    Welsh, Justine W., Dopp, Alex R., Durham, Rebecca M., Sitar, Siara I., Passetti, Lora L., Hunter, Sarah B., Godley, Mark D., Winters, Ken C. · 2025 · Journal of the American Academy of Child &amp; Adolescent Psychiatry
  14. Psychosocial and Pharmacological Interventions for the Treatment of Cannabis Use Disorder
    Pamela Sabioni, Bernard Le Foll · 2019 · FOCUS The Journal of Lifelong Learning in Psychiatry
  15. The role of depressive symptoms in treatment of adolescent cannabis use disorder with N-Acetylcysteine
    Rachel L. Tomko, Amanda K. Gilmore, Kevin Michael Gray · 2018 · Addictive Behaviors
  16. N-acetylcysteine for the treatment of comorbid alcohol use disorder and posttraumatic stress disorder: Design and methodology of a randomized clinical trial
    Sudie E. Back, Kevin Michael Gray, Elizabeth J. Santa Ana, Jennifer Lynn Jones, Amber M. Jarnecke, Jane E. Joseph, James J. Prisciandaro, Therese K. Killeen, Delisa G. Brown, Linda Taimina et al. · 2020 · Contemporary Clinical Trials
  17. Open-label pilot study of quetiapine treatment for cannabis dependence
    John J. Mariani, Martina Pavlicová, Agnieszka K. Mamczur, Adam M. Bisaga, Edward V. Nunes, FRANCES RUDNICK LEVIN · 2014 · The American Journal of Drug and Alcohol Abuse
  18. N-acetyl cysteine in the treatment of cannabis use disorder: A systematic review of clinical trials
    Rishi Sharma, Sai Krishna Tikka, Ashish Ramesh Bhute, Binaya Kumar Bastia · 2022 · Addictive Behaviors
  19. Toward early estimation and treatment of addiction vulnerability: radial arm maze and N-acetyl cysteine before cocaine sensitization or nicotine self-administration in neonatal ventral hippocampal lesion rats
    Kalyan N. Rao, Alena M. Sentir, Eric A. Engleman, Richard L. Bell, Leslie A. Hulvershorn, Alan F. Breier, Robert Andrew Chambers · 2016 · Psychopharmacology
  20. A Preliminary Investigation Of Repetitive Transcranial Magnetic Stimulation Applied To The Left Dorsolateral Prefrontal Cortex In Treatment Seeking Participants With Cannabis Use Disorder
    Gregory L. Sahlem, Bohye Kim, Nathaniel L. Baker, Brendan L. Wong, Margaret A. Caruso, Lauren A. Campbell, Irakli Kaloani, Brian J. Sherman, Tiffany J. Ford, Ahmad H. Musleh et al. · 2023 · Drug and Alcohol Dependence
  21. Needed Relapse-Prevention Research on Novel Framework (ASPIRE Model) for Substance Use Disorders Treatment
    Udi E. Ghitza · 2015 · Frontiers in Psychiatry
  22. Effectiveness of N-acetylcysteine in Treating Clinical Symptoms of Substance Abuse and Dependence: A Meta-analysis of Randomized Controlled Trials
    Chung-Ting Chang, Pei-Ju Hsieh, Hsin‐Chien Lee, Chun-Hong Lo, Ka‐Wai Tam, El‐Wui Loh · 2021 · Clinical Psychopharmacology and Neuroscience
  23. Pharmacotherapy for Substance Use Disorders in Youths
    Christopher Joseph Hammond, Kevin Michael Gray · 2016 · Journal of Child & Adolescent Substance Abuse
  24. Association of Cannabis Use Reduction With Improved Functional Outcomes: An Exploratory Aggregated Analysis From Seven Cannabis Use Disorder Treatment Trials to Extract Data-Driven Cannabis Reduction Metrics
    Erin A. McClure, Brian Neelon, Rachel L. Tomko, Kevin Michael Gray, Aimee L. McRae‐Clark, Nathaniel L. Baker · 2024 · American Journal of Psychiatry
  25. Screening Medications for the Treatment of Cannabis Use Disorder
    L.V. Panlilio, Zuzana Justinová, José Manuel Trigo, Bernard Le Foll · 2016 · International review of neurobiology
  26. Minding the brain: the role of pharmacotherapy in substance-use disorder treatment
    Elias Dakwar, Herbert D. Kleber · 2017 · Dialogues in Clinical Neuroscience
  27. Using Ecological Momentary Assessment to Identify Mechanisms of Change: An Application From a Pharmacotherapy Trial With Adolescent Cannabis Users
    Hayley Treloar Padovano, Robert Miranda · 2018 · Journal of Studies on Alcohol and Drugs
  28. Pharmacotherapies for Cannabis Use Disorders: Clinical Challenges and Promising Therapeutic Agents
    Suzanne Nielsen, Pamela Sabioni, Linda Gowing, Bernard Le Foll · 2019 · Handbook of experimental pharmacology
  29. Treatment of Adolescent Cannabis Use Disorders
    Zachary W. Adams, Brigid R. Marriott, L. Hulvershorn, J. Hinckley · 2022 · Child and Adolescent Psychiatric Clinics of North America
  30. Intrusive thinking: Circuit and synaptic mechanisms of a transdiagnostic psychiatric symptom
    Peter W. Kalivas, Shannon L. Gourley, Martin P. Paulus · 2023 · Neuroscience & Biobehavioral Reviews
  31. Emerging Pharmacologic Treatments for Adolescent Substance Use: Challenges and New Directions
    Robert Miranda, Hayley Treloar Padovano · 2016 · Current Addiction Reports
  32. ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis
    Sue Cotton, M. Berk, Amity Watson, Stephen James Wood, Kelly Allott, Cali Bartholomeusz, Chiara C. Bortolasci, Ken R. Walder, Brian N. O'Donoghue, Olivia May Dean et al. · 2019 · Trials
  33. Evaluating N-acetylcysteine for early and end-of-treatment abstinence in adult cigarette smokers
    Erin A. McClure, Amy E. Wahlquist, Rachel L. Tomko, Nathaniel L. Baker, Matthew J. Carpenter, Elizabeth Bradley, Patrick A. Cato, Cassandra D. Gipson, Kevin Michael Gray · 2021 · Drug and Alcohol Dependence
  34. Integrative Pharmacology in the Treatment of Substance Use Disorders
    Jack Donlon, Pooja Kumari, Sajoy Purathumuriyil Varghese, Michael Y. Bai, Ori David Florentin, Emma D. Frost, John Banks, Niyathi Vadlapatla, Olivia Kam, Mujeeb Uddin Shad et al. · 2023 · Journal of Dual Diagnosis
  35. New Developments in Understanding and Treating Adolescent Marijuana Dependence
    Kevin Michael Gray · 2014 · Adolescent Psychiatry
  36. Open-label pilot study of injectable naltrexone for cannabis dependence
    Daniel P. Notzon, Meredith A. Kelly, C. Jean Choi, Martina Pavlicová, Amy L. Mahony, Daniel J. Brooks, John J. Mariani, FRANCES RUDNICK LEVIN · 2018 · The American Journal of Drug and Alcohol Abuse
  37. Care of the Patient Using Cannabis
    Arthur Robin Williams, Kevin P. Hill · 2020 · Annals of Internal Medicine
  38. Cannabinoids for the treatment of cannabis use disorder: New avenues for reaching and helping youth?
    Kristine Rømer Thomsen, Birgitte Thylstrup, Emily A. Kenyon, Rachel Lees, Lone Baandrup, Sarah W. Feldstein Ewing, Tom P. Freeman · 2021 · Neuroscience & Biobehavioral Reviews
  39. Neurogenetic and Epigenetic Aspects of Cannabinoids
    Catherine A. Dennen, Kenneth Blum, Abdalla Bowirrat, Jag H. Khalsa, Panayotis K. Thanos, David A. Baron, Rajendra Dhar Badgaiyan, Ashim Gupta, Eric R. Braverman, Mark S. Gold · 2022 · Epigenomes
  40. New Directions in Medication-Facilitated Behavioral Treatment for Substance Use Disorders
    Elias Dakwar, Edward V. Nunes · 2016 · Current Psychiatry Reports
  41. Attenuation of toluene-induced brain stimulation reward enhancement and behavioral disturbances by N-acetylcysteine in mice
    Chia‐Yen Wu, Yi-Lin Tsai, Chung-Pin Hsieh, Tsui Chin Wang, Ming‐Huan Chan, Hwei‐Hsien Chen · 2018 · Toxicology
  42. Cannabis and the Current State of Treatment for Cannabis Use Disorder
    Arthur Robin Williams, Kevin P. Hill · 2019 · FOCUS The Journal of Lifelong Learning in Psychiatry
  43. N-acetylcysteine does not alter neurometabolite levels in non-treatment seeking adolescents who use alcohol heavily: A preliminary randomized clinical trial
    Anna E. Kirkland, Brittney D. Browning, ReJoyce Green, Helen Liu, Anna M. Maralit, Pamela Lynn Ferguson, Dieter Johannes Meyerhoff, James J. Prisciandaro, Robert Miranda, Kathleen T. Brady et al. · 2023 · Neuropsychopharmacology
  44. The Neurocircuitry of Substance Use Disorder, Treatment, and Change: A Resource for Clinical Psychiatrists
    Caesar G. Imperio, FRANCES RUDNICK LEVIN, Diana Martínez · 2024 · American Journal of Psychiatry
  45. When and How to Treat Possible Cannabis Use Disorder
    Annie Lévesque, Bernard Le Foll · 2018 · Medical Clinics of North America
  46. Use of N-Acetylcysteine in Psychiatric Conditions among Children and Adolescents: A Scoping Review
    Sadiq Naveed, A. Amray, A. Waqas, A. M. Chaudhary, M. Azeem · 2017 · Cureus
  47. Pharmacotherapies for cannabis use disorder
    Francesca Spiga, Thomas Parkhouse, Victor M. Tang, Jelena Savović, Bernard Le Foll, Suzanne Nielsen · 2025 · Cochrane Database of Systematic Reviews
  48. Treating Executive Function in Youth With Attention Deficit Hyperactivity Disorder: A Review of Pharmacological and Non-Pharmacological Interventions
    Timothy E. Wilens, Mira Stone, Sylvia R. Lanni, Amy F. Berger, Ronan L. H. Wilson, Melis Lydston, Craig Bruce Hackett Surman · 2024 · Journal of Attention Disorders
  49. N-acetylcysteine for youth cannabis use disorder: randomized controlled trial main findings
    Kevin Michael Gray, Rachel L. Tomko, Nathaniel L. Baker, Erin A. McClure, Aimee L. McRae‐Clark, Lindsay M. Squeglia · 2025 · Neuropsychopharmacology
  50. N-acetylcysteine improves impulse control and attenuates relapse-like alcohol intake in long-term drinking rats
    Ida Fredriksson, Nitya Jayaram‐Lindström, Peter W. Kalivas, Philippe A. Melas, Pia Steensland · 2022 · Behavioural Brain Research
  51. Learning and Memory in Addiction
    Stephanie A Carmack, George F. Koob, Stephan Anagnostaras · 2017 · Elsevier eBooks
  52. Clinical Approaches to Cannabis
    Deepika E. Slawek, Susanna A. Curtis, Julia Hope Arnsten, Chinazo O. Cunningham · 2021 · Medical Clinics of North America
  53. Pharmacological cognitive enhancers
    MacKenzie R. Peltier, Mehmet Sofuoglu · 2019 · Elsevier eBooks
  54. Management of Complex Co-occurring Psychiatric Disorders and High-Risk Behaviors in Adolescence
    Justine W. Welsh, Maggie J. Mataczynski, Dana B. Sarvey, Jessica E. Zoltani · 2020 · FOCUS The Journal of Lifelong Learning in Psychiatry
  55. Who responds to a multi‐component treatment for cannabis use disorder? Using multivariable and machine learning models to classify treatment responders and non‐responders
    Rachel L. Tomko, Bethany Jacobs Wolf, Erin A. McClure, Matthew J. Carpenter, Kathryn Marley Magruder, Lindsay M. Squeglia, Kevin Michael Gray · 2023 · Addiction
  56. Objective and subjective memory ratings in cannabis-dependent adolescents
    Erin A. McClure, Jessica B. Lydiard, Scott D. Goddard, Kevin Michael Gray · 2015 · American Journal on Addictions
  57. Evidence Base on Outpatient Behavioral Treatments for Adolescent Substance Use, Update 2018–2023: Current Status, Best Practices, and Opportunities for Advancing the Science
    Aaron Hogue, Nicole Porter, Craig E. Henderson, Timothy J. Ozechowski, Kevin Wenzel, Marc J. Fishman, Sara J. Becker · 2025 · Journal of Clinical Child & Adolescent Psychology
  58. Clinical approach to the treatment of e-cigarette use among adolescents
    Sivabalaji Kaliamurthy, Deepa R. Camenga · 2022 · Current problems in pediatric and adolescent health care
  59. Interventions for Youth at Risk of Bipolar Disorder
    Anne Cecilia Duffy · 2014 · Current Treatment Options in Psychiatry
  60. Pediatric Treatment-Resistant Obsessive Compulsive Disorder: Treatment Options and Challenges
    Sana Younus, Lauren K. Havel, Jordan T. Stiede, Catherine E. Rast, Kirti Saxena, Wayne K. Goodman, Eric A. Storch · 2024 · Pediatric Drugs
  61. Evidence-based consensus guidelines for the pharmacological management of substance dependence: Recommendations from the British Association for Psychopharmacology
    Julia Sinclair, Nicola J. Kalk, Stephen John Kaar, Roberta Agabio, Shalini Arunogiri, Adam M. Bisaga, Edward Chesney, Chris Daly, Jonathan Dewhurst, Tom P. Freeman et al. · 2026 · Journal of Psychopharmacology
  62. Correlates of cannabis use and cannabis use disorder among adolescents with major depressive disorder and bipolar disorder in the National Comorbidity Survey-Adolescent Supplement (NCS-A)
    Alysha A. Sultan, Benjamin I. Goldstein, Carlos Blanco, Kody G. Kennedy, Kevin Paul Conway, Jian-Ping He, Kathleen Ries Merikangas · 2024 · Journal of Affective Disorders
  63. Organic and Synthetic Cannabinoid Use in Adolescents
    Sanaa Bhatty, Wendell Wu · 2013 · Pediatric Annals
  64. A Cannabinoid Hypothesis of Schizophrenia: Pathways to Psychosis.
    Rachel Little, Dale A. D’Mello · 2022 · PubMed Central
  65. The Impacts of Adolescent Cannabinoid Exposure on Striatal Anxiety- and Depressive-Like Pathophysiology Are Prevented by the Antioxidant N-Acetylcysteine
    Marta De Felice, Hanna J. Szkudlarek, Taygun C. Uzuneser, Mar Rodríguez-Ruiz, Mohammed Halit Sarikahya, Mathusha Pusparajah, Juan Pablo Galindo Lazo, Shawn Narain Whitehead, Ken K.‐C. Yeung, Walter J. Rushlow et al. · 2024 · Biological Psychiatry Global Open Science
  66. Exploring Novel Pharmacotherapy Candidates for Cannabis Use Disorder: Uncovering Promising Agents on the Horizon by Mechanism of Action
    Myra Alayoubi, Brittany A. Henry, Catherine M. Cahill, Ziva D. Cooper · 2024 · Drugs
  67. Novel Pharmacotherapeutic Interventions for Cannabis Use Disorder
    Brittany L. Mason, Alaa Mustafa, Francesca Mapua Filbey, E. Sherwood Brown · 2016 · Current Addiction Reports
  68. Behavioral Interventions and Pharmacotherapies for Cannabis Use Disorder
    Aaron J. Bobb, Kevin P. Hill · 2014 · Current Treatment Options in Psychiatry
  69. Findings from a pilot open-label trial of N-acetylcysteine for the treatment of pediatric mania and hypomania
    Janet R. Wozniak, Maura DiSalvo, Abigail Farrell, Carrie Vaudreuil, Mai Uchida, Tolga Atilla Ceranoglu, Gagan Joshi, Emmaline Cook, Stephen V. Faraone, Joseph Biederman · 2022 · BMC Psychiatry
  70. Cannabis Use Disorder as a Developmental Disorder
    Rachel L. Tomko, Amber N. Williamson, Aimee L. McRae‐Clark, Kevin Michael Gray · 2018 · Springer eBooks
  71. Clearing up the smoke: Physical and mental health considerations regarding cannabis use in adolescents with cystic fibrosis
    H. Yavuz Ince, Hanna Phan, Samya Z. Nasr, Jessica Pierce, Nasuh Malas · 2022 · Pediatric Pulmonology
  72. Effects of waterpipe tobacco smoke and ceftriaxone treatment on the expression of endocannabinoid receptors in mesocorticolimbic brain regions
    Alaa M. Hammad, Sara Jamal Meknas, Frank Scott Hall, Suhair Hikmat, Youssef Sari, T.M. Al-Qirim, Malek Alfaraj, Haneen A. Amawi · 2022 · Brain Research Bulletin
  73. Mood Disorders in Youth
    Kirti Saxena, Sherin R. Kurian, Reena R. Kumar, Lawrence Eugene Arnold, Deborah Risher Simkin · 2023 · Child and Adolescent Psychiatric Clinics of North America
  74. Advances in the management of bipolar disorder in children and adolescents: an update on the literature
    Andrea Amerio, Gabriele Arduino, Fabio Fesce, Alessandra Costanza, Andrea Aguglia, Mario Amore, Gianluca Serafini · 2024 · Expert Review of Neurotherapeutics
  75. Pharmacotherapy for Adolescents with Substance Use Disorders
    Darren Courtney, Robert Milin · 2015 · Current Treatment Options in Psychiatry
  76. Psychosocial interventions among children and adolescents
    Preeti Jacob, Deepak Jayarajan · 2018 · Indian Journal of Psychiatry
  77. The Treatment of Cannabis Use Disorder
    Itai Danovitch, David A. Gorelick · 2018 · Elsevier eBooks
  78. Accumbens nNOS Interneurons Regulate Cocaine Relapse
    Alexander C.W. Smith, Michael D. Scofield, Jasper A. Heinsbroek, Cassandra D. Gipson, Daniela N. Neuhofer, Douglas Roberts-Wolfe, Sade M. Spencer, Constanza García‐Keller, Neringa M. Stankeviciute, Rachel J. Smith et al. · 2017 · Journal of Neuroscience
  79. Mechanistic Effects and Use of N-acetylcysteine in Substance Use Disorders
    Norman R. Greenberg, Farzaneh Farhadi, Benjamin Kazer, Marc Nicholas Potenza, Gustavo A. Angarita · 2022 · Current Behavioral Neuroscience Reports
  80. Treatment of Cannabis Use Disorders
    Divya Ramesh, Margaret Haney · 2014 · Springer eBooks
  81. Nutrients, Phytomedicines, and Mind-Body Treatments for Substance Abuse
    Richard P. Brown, Patricia L. Gerbarg · 2014 · Springer eBooks
  82. A Randomized Controlled Trial of N-acetylcysteine for Adolescent and Young Adult Alcohol Use Disorder
    Lindsay M. Squeglia, Rachel L. Tomko, Nathaniel L. Baker, Anna E. Kirkland, Erin A. McClure, Kevin Michael Gray · 2025 · Journal of the American Academy of Child & Adolescent Psychiatry
  83. Treatment of Adolescent Cannabis Use Disorders
    Zachary W. Adams, Brigid R. Marriott, L. Hulvershorn, J. Hinckley · 2023 · Psychiatric Clinics of North America
  84. Astrocyte-Neuron Interactions in Substance Use Disorders
    Eden V. Harder, Janay P. Franklin, Jonathan W. VanRyzin, Kathryn J. Reissner · 2024 · Advances in neurobiology
  85. N-Acetyl-S-(N,N-diethylcarbamoyl) cysteine in rat nucleus accumbens, medial prefrontal cortex, and in rat and human plasma after disulfiram administration
    Robert D. Winefield, Anthonius A. M. Heemskerk, Swetha Kaul, Todd D. Williams, Michael J. Caspers, Thomas Edward Prisinzano, Elinore F. McCance‐Katz, Craig E. Lunte, Morris D. Faiman · 2015 · Journal of Pharmaceutical and Biomedical Analysis
  86. Clinical Approach to the Heavy Cannabis User in the Age of Medical Marijuana
    Timmen L. Cermak · 2016 · Journal of Psychoactive Drugs
  87. Pharmacological Treatment of Substance Use Disorders
    A. Benjamin Srivastava, FRANCES RUDNICK LEVIN, Edward V. Nunes · 2023 · Springer eBooks
  88. Towards a New Dynamic Interaction Model of Adolescent CUD Manifestation, Prevention, and Treatment: A Narrative Review
    Wesley Oosten, Elena Vos, Leontien Los, Michel Nelwan, Toine Pieters · 2023 · Psychoactives
  89. Clinical Treatment of Addictive Disorders with N-Acetylcysteine
    Gregory L. Powell, Erin A. McClure, Michael Foster Olive, Cassandra D. Gipson · 2018 · Springer eBooks
  90. Update on the Neuropsychiatry of Substance Use Disorders
    George Kolodner, Vassilis E. Koliatsos · 2020 · Psychiatric Clinics of North America
  91. Emerging Roles for Glial Pathology in Addiction
    Kathryn J. Reissner, Peter W. Kalivas · 2014 · Springer eBooks
  92. Pharmacological Treatment of Substance Abuse Disorders
    Wilfrid N. Raby, John J. Mariani, FRANCES RUDNICK LEVIN, Edward V. Nunes · 2015 · Wiley eBooks
  93. A Preliminary Investigation Of Repetitive Transcranial Magnetic Stimulation Applied To The Left Dorsolateral Prefrontal Cortex In Treatment Seeking Participants With Cannabis Use Disorder
    Gregory L. Sahlem, Bohye Kim, Nathaniel L. Baker, Brendan L. Wong, Margaret A. Caruso, Lauren A. Campbell, Irakli Kaloani, Brian J. Sherman, Tiffany J. Ford, Ahmad H. Musleh et al. · 2023 · medRxiv
  94. Beyond abstinence: Redefining success in cannabis use disorder treatment
    Tobias Atkin, FRANCES RUDNICK LEVIN, JOHN MARIANI, Christina Brezing · 2026 · Addiction
  95. Exploring the Utility of a Functional Magnetic Resonance Imaging (fMRI) Cannabis Cue-Reactivity Paradigm in Treatment Seeking Adults with Cannabis Use Disorder
    Gregory L. Sahlem, Logan Thorne Dowdle, Nathaniel L. Baker, Brian J. Sherman, Kevin Michael Gray, Aimee L. McRae‐Clark, Brett Froeliger, Lindsay M. Squeglia · 2023 · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
  96. Emerging pharmacological strategies for the treatment of cannabis use disorder
    Anees Bahji · 2025 · Expert Opinion on Pharmacotherapy
  97. The Emerging Role of N-Acetylcysteine in Psychiatry: A Narrative Review of Available Data
    Donatella Marazziti, Valerio Caruso, Gabriele Cappellato, Ilaria Chiarantini, Riccardo Gurrieri, Paola Perrone, Miriam Violi, Nicola Schulz Bizzozzero Crivelli, Francesco Weiss, Giulio Perugi · 2025 · Current Medicinal Chemistry
  98. School‐Based Services May Eliminate Substance Treatment Disparities: Results From a Nonrandomized Program Evaluation
    Christian Thurstone, Ryan M. Loh, Sonja O’Leary, Sophia Bruce, Kristie M. Ladegard · 2023 · Journal of School Health
  99. The Cannabis Ask: What's a Psychiatrist to Do?
    Darren Courtney, Christopher Joseph Hammond, Bushra Rizwan, Simon Giasson, Mona Gupta · 2022 · PubMed Central
  100. Treatment Strategies for Cannabis Use in Schizophrenia
    Brian Schultz, Lisette Rodriguez-Cabezas, Dan Angres, Matthew J. Smith · 2015 · Current Treatment Options in Psychiatry